Rotavirus in africa: Shifting the focus to disease prevention

Journal of Infectious Diseases

Volumn 202, Issue SUPPL. 1, 2010, Pages

  Neuzil, Kathleen M ^a   Armah, George E ^c   Parashar, Umesh D ^b   Steele, A Duncan ^a  

^a PATH   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c University of Ghana   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

AFRICA; CAUSE OF DEATH; CHILDHOOD MORTALITY; CLINICAL TRIAL; DRUG SAFETY; EDITORIAL; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INTUSSUSCEPTION; LOWEST INCOME GROUP; MORBIDITY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; ROTAVIRUS; ROTAVIRUS INFECTION; WORLD HEALTH ORGANIZATION;

AFRICA; CHILD, PRESCHOOL; HEALTH POLICY; HUMANS; IMMUNIZATION PROGRAMS; INFANT; POPULATION SURVEILLANCE; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; WORLD HEALTH ORGANIZATION;

EID: 77955666135     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/653545     Document Type: Editorial

References (22)

1. Meeting of the immunization Strategic Advisory Group of Experts: conclusions and recommendations. Wkly Epidemiol Rec 2009; 84: 220-235.
2. WHO rotavirus vaccine position paper. Wkly Epidemiol Rec 2007; 82:285-296.
3. Steele AD, Alexander JJ, Hay IT. Rotavirus associated gastroenteritis in black infants in South Africa. J Clin Microbiol 1986; 23: 992-994.
4. Armah GE, Mingle JA, Dodoo AK, et al. Seasonality of rotavirus infection in Ghana. Ann Trop Paediatr 1994; 14(3):223-229.
5. Mpabalwani M, Oshitani H, Kasolo F, et al. Rotavirus gastro-enteritis in hospitalized children with acute diarrhoea in Zambia. Ann Trop Paediatr 1995; 15(1):39-43.
6. Cunliffe NA, Kilgore PE, Breese JS, et al. Epidemiology of rotavirus diarrhoea in Africa: a review of studies to anticipate rotavirus immunization. Bull WHO 1998; 76: 525-537.
7. Global networks for surveillance of rotavirus gastroenteritis, 2001-2008. Wkly Epidemiol Rec 2008; 83:421-424.
8. World Health Organization. Estimated rotavirus deaths for children under 5 years of age: 2004, 527 000. http://www.who.int/ immunization-monitoring/ burden/rotavirus-estimates/en/index.html. Published 2006. Accessed 7 July 2010.
9. Goveia MG, Nelson CB, Ciarlet M. RotaTeq: progress toward developing world access. J Infect Dis 2010; 202:87-92 (in this issue).
10. Han HH. Rotarix: GlaxoSmithKline's commitment to the developing world: paving the way for universal mass vaccination in Africa. J Infect Dis 2010; 202:80-86 (in this issue).
11. O'Ryan M. Rotarix (RIX4414): a human oral rotavirus Vaccine. Expert Rev Vaccines 2007; 6(1):11-19.
12. Heaton PM and Ciarlet M. Pentavalent rotavirus vaccine: discovery to licensure and beyond. Clin Infect Dis 2007; 45(12):1618-1624.
13. Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in AFrican infants. N Engl J Med 2010; 362: 289-298.
14. Armah GE, Sow SO, Breiman RF, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroentiritis in infants in developing countries in sub-Saharan Africa: a randomised, double-bling, placebo-controlled trial. Lancet 2010 (in press).
15. Zaman K, Anh DD, Victor JC, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroentiritis in infants in developing countries in Asia: a randomised, double- bling, placebo-controlled trial. Lancet 2010 (in press).
16. Cunliffe NA, Gondwe JS, Broadhead RL, et al. Rotavirus G and P types in children with acute diarrhea in Blantyre, Malawi, from 1997 to 1998: predominance of novel P[6]G8 strains. J Med Virol 1999; 57(3):308-312.
17. Esona MD, Geyer A, Banyai K, et al. Novel human rotavirus genotype G5P[7] from child with diarrhea, Cameroon. Emerg Infect Dis 2009; 15:83-86.
18. Page NA, de Beer MC, Seheri LM, Dewar JB, Steele AD. The detection and molecular characterization of human G12 genotypes in South Africa. J Med Virol 2009; 81:106-113.
19. Clarke A, Sanderson C. Timing of children's vaccinations in 45 low-income and middleincome countries: an analysis of survey data. Lancet 2009; 373(9674):1543-1549.
20. Patel MM, Clark AD, Glass RI, et al. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception. Vaccine 2009; 27(22):2916-2922.
21. Jiang B, Gentsch JR, Glass RI. Inactivated rotavirus vaccines: a priority for accelerated vaccine development. Vaccine 2008; 26(52): 6754-6758.
22. USAID, UNICEF, World Health Organization. Diarrhoea treatment guidelines including new recommendations for the use of ORS and zinc supplementations for clinic-based health care workers. Published 2005. http:// www.who.int/child- adolescent-health/documents/ a85500/en/. Accessed 7 July 2010.